Ditchcarbon
  • Contact
  1. Organizations
  2. OncoDNA SA
Public Profile
Business Services
BE
updated 2 months ago

OncoDNA SA Sustainability Profile

Company website

OncoDNA SA, headquartered in Belgium, is a pioneering company in the field of precision medicine, specialising in oncology. Founded in 2014, OncoDNA has established itself as a leader in genomic profiling and personalised treatment solutions, focusing on improving patient outcomes in cancer care. The company offers a range of innovative products and services, including comprehensive genomic tests that provide critical insights into tumour characteristics, enabling tailored therapeutic strategies. OncoDNA's unique approach combines advanced bioinformatics with a robust database of clinical outcomes, setting it apart in the competitive landscape of cancer diagnostics. With a strong presence in Europe and expanding operations globally, OncoDNA has achieved significant milestones, including partnerships with leading healthcare institutions and recognition for its contributions to personalised medicine.

DitchCarbon Score

How does OncoDNA SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

26

Industry Average

Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

29

Industry Benchmark

OncoDNA SA's score of 26 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.

43%

Let us know if this data was useful to you

OncoDNA SA's reported carbon emissions

OncoDNA SA, headquartered in Belgium, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that OncoDNA SA may still be in the early stages of developing a comprehensive climate strategy. In the context of the biotechnology industry, many companies are increasingly focusing on sustainability and carbon footprint reduction. However, without specific initiatives or targets, OncoDNA SA's climate commitments remain unclear. As the industry evolves, it will be essential for OncoDNA SA to establish measurable goals and transparent reporting to align with global climate action efforts.

How Carbon Intensive is OncoDNA SA's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. OncoDNA SA's primary industry is Business Services, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is OncoDNA SA's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for OncoDNA SA is in BE, which has a very low grid carbon intensity relative to other regions.

OncoDNA SA's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

OncoDNA SA has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare OncoDNA SA's Emissions with Industry Peers

Thermo Fisher Scientific

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Foundation Medicine, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 months ago

Tempus AI

US
•
Other business services (74)
Updated 14 days ago

Myriad Genetics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Celsee, Inc.

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 3 months ago

GRAIL, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251204.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy